Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma

Background: Although the introduction of protease inhibitor bortezomib (BTZ) and immunomodulatory agent lenalidomide has led to improved outcomes in patients with multiple myeloma (MM), the disease remains incurable. Gambogenic acid (GNA), a polyprenylated xanthone isolated from the traditional Chin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Cancer
Main Authors: Chen, Runzhe, Zhang, Hongming, Liu, Ping, Wu, Xue, Chen, Baoan
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2017
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5381173/
https://ncbi.nlm.nih.gov/pubmed/28382147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.17657
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki